Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · IEX Real-Time Price · USD
19.42
-0.95 (-4.66%)
At close: Jul 19, 2024, 4:00 PM
19.80
+0.38 (1.96%)
Pre-market: Jul 22, 2024, 7:36 AM EDT
Hims & Hers Health Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Hims & Hers Health stock have an average target of 18.5, with a low estimate of 11 and a high estimate of 26. The average target predicts a decrease of -4.74% from the current stock price of 19.42.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HIMS stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 3 | 4 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 5 | 5 | 5 | 7 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 11 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $15 → $25 | Strong Buy | Maintains | $15 → $25 | +28.73% | Jul 11, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $16 → $18 | Hold | Maintains | $16 → $18 | -7.31% | Jul 11, 2024 |
| Jefferies | Jefferies | Hold Maintains $14 → $23 | Hold | Maintains | $14 → $23 | +18.43% | Jun 27, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $22 → $26 | Strong Buy | Maintains | $22 → $26 | +33.88% | Jun 13, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $17 → $22 | Strong Buy | Maintains | $17 → $22 | +13.29% | Jun 3, 2024 |
Financial Forecast
Revenue This Year
1.25B
from 872.00M
Increased by 42.78%
Revenue Next Year
1.55B
from 1.25B
Increased by 24.58%
EPS This Year
0.17
from -0.11
EPS Next Year
0.32
from 0.17
Increased by 93.00%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.3B | 1.7B | 2.1B | 3.0B | 2.3B |
| Avg | 1.2B | 1.6B | 1.9B | 2.3B | 2.2B |
| Low | 1.2B | 1.4B | 1.7B | 1.9B | 2.1B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 49.1% | 33.3% | 33.3% | 61.0% | 3.6% |
| Avg | 42.8% | 24.6% | 20.4% | 21.4% | -2.1% |
| Low | 35.0% | 15.6% | 7.4% | 0.6% | -8.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.23 | 0.58 | 0.76 | 1.28 | 1.46 |
| Avg | 0.17 | 0.32 | 0.48 | 1.19 | 1.42 |
| Low | 0.09 | 0.18 | 0.30 | 1.09 | 1.36 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 248.5% | 136.3% | 167.7% | 22.8% |
| Avg | - | 93.0% | 48.6% | 148.3% | 19.3% |
| Low | - | 5.7% | -5.7% | 127.3% | 14.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.